The Next Shift in Care Delivery
We like to believe healthcare is designed around patients.
But most of the time, it’s not.
It’s designed around systems—labs, workflows, reimbursement structures, and idealized care pathways that assume people have the time, access, and ability to come back, follow up, and navigate complexity without friction.
Real life doesn’t work that way.
Women miss appointments. Results take time. Follow-up gets delayed.
Take Anne—a working mom balancing a full-time job, two kids, and everything in between. She schedules her screening, makes the appointment work, and then waits. When results come back, she’s asked to return for follow-up—but finding another opening means rearranging work, childcare, and already full days. Weeks pass. What started as a simple step becomes a series of hurdles.
And in that space between intention and reality, we lose people like Anne—not because they don’t care, but because the system wasn’t built for how care actually happens.
If we want to change outcomes, we don’t just need better tests.
We need to design diagnostics for the real world.
The System Was Built for Ideal Conditions
Traditional diagnostic pathways follow a familiar sequence: test, send to lab, wait for results, return for follow-up, then decide on next steps.
On paper, it’s efficient. In practice, it assumes something far less reliable—perfect conditions.
It assumes patients can return easily. That schedules align. That nothing gets in the way.
Healthcare systems are optimized for process efficiency—not for human behavior.
Where the System Breaks Down
The gap between intention and action is where outcomes are lost.
A significant percentage of women are not up to date on recommended screening—not due to lack of awareness, but because of friction in the system. Time constraints, transportation challenges, work and childcare responsibilities, and even the emotional weight of uncertainty all play a role.
Missed follow-ups and delayed care are not edge cases. They are the norm.
And every additional step in the process increases the likelihood that someone falls through the cracks—someone like Anne, who did everything right but still faces barriers the system didn’t account for.
Designing for Real Life, Not Ideal Workflows
What if we started from a different place?
Not with the system—but with the patient journey.
Designing for real life means prioritizing what actually drives follow-through:
Speed
Simplicity
Accessibility
The most impactful innovations don’t add complexity—they remove it.
Diagnostics should minimize steps, reduce reliance on centralized infrastructure, and, when possible, enable action in the same encounter.
Because when care happens in one visit instead of three, outcomes change.
The Shift Toward Point-of-Care Diagnostics
We’re already seeing this shift.
The COVID era accelerated the acceptance of rapid, decentralized testing and reset expectations around how quickly answers should be available.
Point-of-care diagnostics are not new—but their role is evolving.
Moving closer to the patient means faster answers, fewer missed follow-ups, and broader access—especially in settings where traditional lab infrastructure creates barriers.
This isn’t a niche trend. It’s a fundamental shift in how care is delivered.
Rethinking What “Good” Looks Like
For decades, diagnostics have been measured by sensitivity and specificity.
Those metrics matter. But they’re not enough.
A more important question is emerging:
Does this test change what happens next?
A test that works in theory but fails in practice isn’t enough.
A test that delivers timely, actionable insight—and fits into real-world workflows—is what ultimately drives better outcomes.
Conclusion
If we’re honest, the gap in healthcare today isn’t just scientific—it’s structural.
We’ve built systems that work beautifully on paper, but too often fall apart in real life.
For patients like Anne, that gap isn’t theoretical—it’s the difference between getting timely care and falling into a cycle of delays and uncertainty.
The next generation of diagnostics won’t just be more advanced. They’ll be more aligned with reality.
They’ll meet patients where they are.
They’ll reduce steps instead of adding them.
And they’ll turn moments of uncertainty into moments of clarity—right when it matters most.
Because better outcomes don’t start in the lab.
They start with designing care for the way life actually works.
Learn more at:
https://screen-her.com/
About the Author
Jennifer Estep is the Founder & CEO of ScreenHER, a women’s health diagnostics company advancing early detection through rapid, non-invasive, point-of-care solutions. A Purdue-trained mechanical engineer and former global medtech commercialization executive, she has led strategy and market development for venture-backed platforms from early stage through IPO trajectory. Jennifer is passionate about building technologies that improve access, accelerate decision-making, and enable better health outcomes at scale.
This is the second in a series on rapid diagnostics and early cancer detection. The first post, “Rapid Diagnostics: The Future of Women’s Cancer Detection Is Already Here,” can be found here: https://screen-her.com/insights/